NTLA icon

Intellia Therapeutics

76 hedge funds and large institutions have $236M invested in Intellia Therapeutics in 2017 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 19 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
76
Holders Change
+6
Holders Change %
+8.57%
% of All Funds
1.89%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
19
Reduced
18
Closed
11
Calls
$478K
Puts
$599K
Net Calls
-$121K
Net Calls Change
-$121K
Name Holding Trade Value Shares
Change
Shares
Change %
LTFS
76
Ladenburg Thalmann Financial Services
Florida
$1K +$1K +100 New
Alyeska Investment Group
77
Alyeska Investment Group
Illinois
-$1.84M -140,000 Closed
Norges Bank
78
Norges Bank
Norway
-$886K -67,571 Closed
SG Americas Securities
79
SG Americas Securities
New York
-$482K -36,794 Closed
Susquehanna International Group
80
Susquehanna International Group
Pennsylvania
-$477K -36,415 Closed
VKH
81
Virtu KCG Holdings
New York
-$269K -20,545 Closed
PA
82
Perceptive Advisors
New York
-$192K -14,673 Closed
CS
83
Credit Suisse
Switzerland
-$162K -12,379 Closed
WCM
84
Wildcat Capital Management
New York
-$46K -3,542 Closed
SO
85
STRS Ohio
Ohio
-$41K -3,200 Closed
TRCT
86
Tower Research Capital (TRC)
New York
-$27K -2,046 Closed
TWMP
87
Taylor Wealth Management Partners
Massachusetts
-$1K -75 Closed